Clinical Trial Update: Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial in melanoma evaluating Tavo with electroporation in combination with nivolumab (Opdivo); results have been posted following completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• OPDIVO (nivolumab)
• Tavo

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2025-05-06